BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30391119)

  • 1. Evidence-based Treatment for Low-grade Glioma.
    Semmel D; Ware C; Kim JY; Peters KB
    Semin Oncol Nurs; 2018 Dec; 34(5):465-471. PubMed ID: 30391119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery and Evidence-based Treatments in Patients with Newly Diagnosed High-grade Glioma.
    Serventi J; Behr J
    Semin Oncol Nurs; 2018 Dec; 34(5):443-453. PubMed ID: 30409553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor Treating Fields: Adjuvant Treatment for High-grade Gliomas.
    Anthony P; McArdle S; McHugh M
    Semin Oncol Nurs; 2018 Dec; 34(5):454-464. PubMed ID: 30413356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and Overview of Gliomas.
    Davis ME
    Semin Oncol Nurs; 2018 Dec; 34(5):420-429. PubMed ID: 30392758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approved Treatments for Patients with Recurrent High-grade Gliomas.
    Laub CK; Stefanik J; Doherty L
    Semin Oncol Nurs; 2018 Dec; 34(5):486-493. PubMed ID: 30392759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction.
    Affronti ML
    Semin Oncol Nurs; 2018 Dec; 34(5):417-419. PubMed ID: 30446381
    [No Abstract]   [Full Text] [Related]  

  • 7. Toward Precision Medicine: Promising Areas of Research in Glioma.
    Davis ME; Bossert D; Manne M
    Semin Oncol Nurs; 2018 Dec; 34(5):569-572. PubMed ID: 30409552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based clinical practice parameter guidelines for the treatment of adults with diffuse low grade glioma: introduction and methods.
    Olson JJ; Kalkanis SN; Ryken TC
    J Neurooncol; 2015 Dec; 125(3):449-56. PubMed ID: 26108657
    [No Abstract]   [Full Text] [Related]  

  • 9. SEOM clinical guideline of diagnosis and management of low-grade glioma (2017).
    Sepúlveda-Sánchez JM; Muñoz Langa J; Arráez MÁ; Fuster J; Hernández Laín A; Reynés G; Rodríguez González V; Vicente E; Vidal Denis M; Gallego Ó
    Clin Transl Oncol; 2018 Jan; 20(1):3-15. PubMed ID: 29124520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End-of-Life Care for Patients with Glioma.
    Honea N
    Semin Oncol Nurs; 2018 Dec; 34(5):553-568. PubMed ID: 30424921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
    Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
    Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Stereotactic Radiotherapy and Bevacizumab for Recurrent High-Grade Gliomas: A Potential Therapy for Isocitrate Dehydrogenase Wild-Type Recurrent High-Grade Gliomas.
    Yasuda T; Muragaki Y; Nitta M; Miyamoto K; Oura Y; Henmi T; Noguchi S; Oda H; Saito T; Maruyama T; Atsuchi S; Miura N; Kawamata T
    World Neurosurg; 2018 Jun; 114():e1138-e1146. PubMed ID: 29614360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newer Strategies for the Management of Low-Grade Gliomas.
    Dixit K; Raizer J
    Oncology (Williston Park); 2017 Sep; 31(9):680-2, 684-5. PubMed ID: 29071695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Input of molecular analysis in medical management of primary brain tumor patients.
    Idbaih A; Duran-Peña A; Bonnet C; Ducray F
    Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subgroup characteristics of insular low-grade glioma based on clinical and molecular analysis of 42 cases.
    Tang C; Zhang ZY; Chen LC; Sun Z; Zhang Y; Qin Z; Yao Y; Zhou LF
    J Neurooncol; 2016 Feb; 126(3):499-507. PubMed ID: 26586262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of low-grade gliomas: genomic alterations guiding diagnosis and therapeutic intervention. 11th annual Frye-Halloran Brain Tumor Symposium.
    Jones PS; Dunn GP; Barker FG; Curry WT; Hochberg FH; Cahill DP
    Neurosurg Focus; 2013 Feb; 34(2):E9. PubMed ID: 23373454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular diagnostic testing in breast cancer.
    Berse B; Lynch JA
    Semin Oncol Nurs; 2015 May; 31(2):108-21. PubMed ID: 25951740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIOP PODC Adapted treatment guidelines for low grade gliomas in low and middle income settings.
    Hessissen L; Parkes J; Amayiri N; Mushtaq N; Sirachainan N; Anacak Y; Mitra D; Figaji A; Schouten-van Meeteren A; Sullivan M; Burger H; Davidson A; Bouffet E; Bailey S
    Pediatr Blood Cancer; 2017 Dec; 64 Suppl 5():. PubMed ID: 29297618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Advance of molecular subtyping and precise treatment for gliomas].
    Hua W; Mao Y
    Zhonghua Wai Ke Za Zhi; 2017 Jan; 55(1):63-66. PubMed ID: 28056258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What's New in Grade II and Grade III Gliomas?
    Miller JJ; Wick W
    Semin Neurol; 2018 Feb; 38(1):41-49. PubMed ID: 29548051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.